A phase II trial of the multitargeted kinase inhibitor lenvatinib (E7080) in advanced medullary thyroid cancer (MTC).
暂无分享，去创建一个
C. Andresen | M. Schlumberger | D. Ball | B. Jarzab | L. Licitra | S. Sherman | R. Elisei | F. Pacini | K. Newbold | L. Burmeister | B. Robinson | Y. Funahashi | R. Martins | J. Mccaffrey | M. Cabanillas | D. Bodenner | J. O'brien | R. Allison | M. Shah | R. Sellecchia